Transferrin, in Visit Clinic

Transferrin is a plasma glycoprotein that binds ferric iron (Fe3+) and transports it from absorption sites and macrophages to bone marrow and other tissues. By tightly binding iron it limits free iron’s oxidative toxicity and makes iron available to cells via transferrin‑receptor‑mediated endocytosis. Clinical measures—transferrin, transferrin saturation and total iron‑binding capacity—help evaluate iron status and disorders of iron metabolism.

Low transferrin reduces iron transport and is seen with liver disease, malnutrition, chronic inflammation and nephrotic syndrome. It lowers total iron‑binding capacity and can contribute to anemia by impairing iron delivery to the marrow, causing fatigue, pallor and increased infection risk. Evaluation usually includes iron studies, liver tests and inflammation markers to identify and treat the underlying cause.

Transferrin is the liver-made protein that carries iron. High transferrin usually signals iron deficiency—your body raises transferrin when iron stores are low, producing low transferrin saturation. Levels can also rise in pregnancy or with estrogen/oral contraceptive use. A high value prompts further evaluation (serum ferritin, iron studies and clinical assessment) to identify and treat underlying causes.

Transferrin is a liver‑made blood protein that binds and transports iron (Fe3+) to cells; transferrin saturation reflects circulating iron availability. Ferritin is an intracellular iron‑storage protein; serum ferritin correlates with total body iron stores. Low ferritin indicates iron deficiency, while high ferritin can signal iron overload or inflammation. Together, they help distinguish iron deficiency from chronic disease or overload.

To raise low transferrin, address underlying causes: improve nutrition with adequate high‑quality protein (meat, dairy, legumes), correct iron deficiency only under medical supervision, and treat infections, inflammation or liver/kidney disease. Avoid self-prescribing iron; get blood tests and repeat monitoring. A clinician can recommend dietary changes, supplements or therapy for chronic conditions to help normalize transferrin and overall iron status.

Yes. The liver makes transferrin, so low transferrin can reflect impaired hepatic synthetic function seen in chronic liver disease or cirrhosis. Transferrin is also a negative acute‑phase reactant, so levels fall with inflammation, malnutrition, nephrotic syndrome or protein loss. Low transferrin alone is not diagnostic; interpret it with clinical context and other liver tests (albumin, INR, enzymes, ferritin).